• AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod

    المصدر: NASDAQ Stocks / 02 أبريل 2024 09:15:53   America/Chicago

    AstraZeneca AZN announced that the FDA had approved Voydeya (danicopan) for treating paroxysmal nocturnal hemoglobinuria (PNH), a rare and chronic blood disorder. https://www.nasdaq.com/articles/astrazenecas-azn-rare-blood-disorder-drug-gets-fda-nod
شارك على،